Week Ending August 16, 2021

‘Game changing’ Former addict who battled Hepatitis C for 20-years opens up on life-changing treatment
“Former heroin user Scott MacBlack, a 42-year-old dad from Irvine, Ayrshire, told how previous interventions did not work and it was only when he went to prison he heard about the Direct Acting Antivirals (DAA) treatment. One pill a day for 12 weeks completely cured the condition he had been battling for 20 years.”

North Adams native receives international recognition for work addressing hepatitis C
“After new treatment became available for hepatitis C, the U.S. Department of Veterans Affairs began an effort to screen and treat more veterans for the infection. At the helm of that initiative: Dr. Angela Park, a North Adams native and clinical pharmacy specialist who works remotely for the Veterans Health Administration based in Washington.”

Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
“Incidence of HCC was significantly lower in patients with HCV-related advanced fibrosis and cirrhosis treated with DAAs than in a historical cohort of untreated patients. Decompensated cirrhosis, baseline AFP ≥ 10 ng/mL, diabetes, and nonresponse to DAA were independent risk factors of incident HCC.”

VA Study Finds Alarming Gaps in Cirrhosis Diagnosis
“New research has found that nearly half of patients who receive care at Veterans Health Administration hospitals have risk factors for liver disease. Yet, fewer than 10% of patients with these risk factors and markedly abnormal fibrosis scoring or transient elastography receive a diagnosis of cirrhosis.”

Approaching the Identification and Management of HCC